Business

Ex-Fauci adviser pleads guilty in US in COVID case

By Sohail Khan 19 August 2026, 9:53 am

Benchmarks
Nifty24,081.00-73.91

FEATURED FUNDS★★★★★

Motilal Oswal Midcap Fund Direct-Growth

5Y Return
23.26 %

Invest Now

Enter search text:

Business News›News›International›World News›Ex-Anthony Fauci adviser pleads guilty in US to conspiring to conceal COVID-19 records

Read Today's Paper

Ex-Anthony Fauci adviser pleads guilty in US to conspiring to conceal COVID-19 records

Synopsis

A former adviser to Anthony Fauci pleaded guilty to conspiring to hide government documents. David Morens admitted to evading public records laws concerning COVID-19 research grants. He faces up to five years in prison for his actions. This plea occurred as COVID's origins remain a subject of debate among intelligence agencies. Morens agreed to use personal email to avoid Freedom of Information Act requests.

Ex-Anthony Fauci adviser pleads guilty in US to conspiring to conceal COVID-19 records — Anthony Fauci, the former Director of the National Institute of Allergy and Infectious Diseases (NIAID) and medical advisor to several U.S. presidents

A former adviser to infectious disease expert Anthony Fauci pleaded guilty on Tuesday to conspiring to evade public records laws and conceal government documents related to grant research funding and the COVID-19 pandemic.

David Morens, who had worked under Fauci as a senior official at the National Institute of Allergy and Infectious Diseases during the pandemic, entered his plea to a conspiracy ‌charge during a ⁠hearing ⁠in federal court in Greenbelt, Maryland.

Also read: Fauci contempt vote clears key Senate committee in COVID probe; why is he being questioned now?

The 78-year-old had been indicted in April on charges related to what prosecutors said was a scheme to thwart public records requests received by the agency beginning in April 2020 related to COVID-19 research grants.

He faces up to five years in prison when he is sentenced on November 12.

"By pleading guilty today, Dr. Morens has taken responsibility for what he did, and he will continue to do ⁠so," Timothy ‌Belevetz, his lawyer, said in a statement.

The plea came after Fauci, who led the NIAID for 38 years and became the face of the U.S. ⁠pandemic response, appeared before a Senate panel last month and repeatedly invoked his right against self-incrimination as he accused Republican Senator Rand Paul, a longtime adversary from Kentucky, of pursuing an "unhinged" campaign to see him imprisoned.

COVID's origins remain unresolved. The FBI said in 2023 that a leak from a Wuhan laboratory likely caused the pandemic, a claim China said had "no credibility whatsoever." The CIA said in January 2025 a lab leak was likely, but with "low confidence," while ‌four other U.S. intelligence agencies and the National Intelligence Council believe the virus most likely emerged via natural transmission from some animal.

Prosecutors said that Morens' plea related to the National ⁠Institutes of Health's decision to cancel a research grant related to bat coronavirus, based on allegations that COVID-19 emerged from the Wuhan lab. The China-based lab had received a sub-award from the company that had received the grant.

Prosecutors said that Morens pledged to help restore the bat coronavirus grant and counter the narrative COVID-19 leaked from a lab.

Anticipating their communications would be sought through Freedom of Information Act requests, Morens and others agreed to correspond using Morens' personal email account instead of his government one, prosecutors said.

(Reporting by Nate Raymond in Boston; Editing by Raju Gopalakrishnan)

Add as a Reliable and Trusted News Source
Add Now!

(You can now subscribe to our WhatsApp channel)

(You can now subscribe to our WhatsApp channel)

Read More News on
David MorensAnthony Fauciconspiracy to conceal documentspublic records lawspandemic responseWuhan laboratory leakFreedom of Information ActNational Institute of Allergy and Infectious Diseasesbat coronavirus grant

Enter search text:

Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories

& personalised newsletters
Login Now

Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions &

in-depth stock reports
Subscribe Now

Unlock Access to All Exclusives with ETPrime FREE TRIAL

15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

Trial offer expiring in00 : 05 : 00

I'd rather pay ₹2599 now

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Prime Account Detected!

It seems like you're already an ETPrime member with

Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

Unlock ETPrime's Exclusive Stories Today!

Subscribe to gain powerful insights on business, stock market and industry trends.

Big Price Drop! Flat 40% Off

Student Only Offer

Already a Member? Sign In now

Already a Member? Sign In now
Already a Member? Sign In now

Offer Exclusively For You

Save up to Rs. 700/-

ON ET PRIME MEMBERSHIP

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get Flat 40% Off

Then ₹ 1749 for 1 year

Avail Offer

Offer Exclusively For You

ET Prime at ₹ 49 for 1 month

Then ₹ 1749 for 1 year

Avail Offer

Special Offer

Get flat 40% off on ETPrime

Avail Offer
Avail Offer

Claim NowAlready a Member? Sign In now

Need Assistance?

Connect with an ETPrime expert for personalized support and guidance

+91 9484700004

' + h3 + '

' + h4 + '

' + listing + '

What’s Included with

ETPrime Membership

1Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with in-depth insights that matter

Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

The problem with lab grown diamonds
Why a falling rupee is a better option for the economy

A list of top 20 momentum stocks that have delivered massive returns in one year